Affiliation:
1. Baylor College of Medicine
2. The University of Texas Rio Grande Valley
3. DHR Health
4. : Texas Children's Hospital
5. Milestones Therapeutic Associates
6. University of Florida Department of Pediatrics
Abstract
Abstract
Background
The utilization of genomic information to improve health outcomes is progressively becoming more common in clinical practice. Nonetheless, disparities persist in accessing genetic services among ethnic minorities, individuals with low socioeconomic status, and other vulnerable populations. The Rio Grande Valley at the Texas-Mexico border is predominantly Hispanic with a high poverty rate and an increased prevalence of birth defects, with very limited access to genetics services. The cost of a diagnosis is often times out of reach for these underserved families. Funded by the National Center for Advancing Translational Sciences (NCATS), Project GIVE (Genetic Inclusion by Virtual Evaluation) was launched in 2022 to shorten the time to diagnosis and alleviate healthcare inequities in this region, with the goal of improving pediatric health outcomes.
Methods
Utilizing Consultagene, an innovative electronic health record (EHR) agnostic virtual telehealth and educational platform, we designed the study to recruit 100 children with rare diseases over a period of two years from this region, through peer-to-peer consultation and referral.
Conclusions
Project GIVE study has allowed advanced genetic evaluation and delivery of genome sequencing through the virtual portal, effectively circumventing the recognized socioeconomic and other barriers within this population. This paper explores the successful community engagement process and implementation of an alternate genomics evaluation platform and testing approach, aiming to reduce the diagnostic journey for individuals with rare diseases residing in a medically underserved region.
Publisher
Research Square Platform LLC
Reference17 articles.
1. The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?;Fraiman YS;Pediatr Res,2021
2. Addressing health disparities in cancer with genomics;Balogun OD;Nat Rev Genet,2021
3. Underrepresentation of non-White children in trials of statins in children with heterozygous familial hypercholesterolemia;Belay B;Ethn Dis,2009
4. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies;Aldrighetti CM;JAMA Netw Open,2021
5. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study;Glenn BA;Ethn Dis,2012